Allain J P
Diagnostics division, Abbott Laboratories, Abbott Park, North Chicago Illinois 60064.
Rev Prat. 1989 Dec 21;39(30):2674-7.
French hemophiliacs have been infected with HIV between 1980 and 1985 initially by american Factor VIII concentrates and later by french Factor VIII and IX concentrates. Viral inactivation methods applied to these plasma derivatives appear to have interrupted infection the rate of which is currently about 50 p. 100. An increasing number of these individuals develop clinical complications related to immunodeficiency and AIDS. Biological tests are available to indicate the intensity of viral replication causing clinical symptoms, and these could be used to initiate an early anti-viral therapy. A major educational effort should be undertaken to limit the HIV infection spread among female sex partners of hemophiliacs.
1980年至1985年间,法国血友病患者最初因使用美国的凝血因子VIII浓缩剂而感染艾滋病毒,后来又因使用法国的凝血因子VIII和IX浓缩剂而感染。应用于这些血浆衍生物的病毒灭活方法似乎已阻断感染,目前感染率约为万分之五十。越来越多的此类患者出现与免疫缺陷和艾滋病相关的临床并发症。现有生物学检测方法可显示导致临床症状的病毒复制强度,这些检测方法可用于启动早期抗病毒治疗。应大力开展教育工作,以限制艾滋病毒在血友病患者女性性伴侣中的传播。